Q4 2019 Inovio Pharmaceuticals Inc Earnings Call Transcript

Mar 12, 2020 / 08:30PM GMT
Operator

Good day and welcome to the INOVIO Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.

Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Good afternoon and thank you for joining the INOVIO Pharmaceuticals' Fourth Quarter and Year-end 2019 Investor Conference Call. With me today are INOVIO's President and CEO, Dr. J. Joseph Kim; our Chief Financial Officer, Mr. Peter Kies; and Senior VP of Research and Development, Dr. Kate Broderick, who will provide an overview on INOVIO's continued efforts regarding the company's DNA vaccine, which is targeting the current COVID-19 outbreak.

Today's call is being webcast live on our website, ir.inovio.com, and a replay of today's call will be made available. Following a general business update, we will conduct a question-and-answer segment, which will be reserved for equity research analysts.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot